
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
2
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
3
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
4
FDA Clears First Single-Inhaler Triple Therapy for Asthma
5











